|
1
|
World Health Organization: Breast cancer:
Prevention and control. <http://www.who.int/cancer/detection/breastcancer/en/index1.html>.
Accessed May 14, 2019. https://www.who.int/cancer/detection/breastcancer/en/index1.html.
|
|
2
|
National Cancer Control Program (NCCP):
‘National Cancer Incidence Data Sri Lanka 2014’: <http://www.nccp.health.gov.lk/images/PDF_PUBLICATIONS/Cancer_Incidence_in_Sri_Lanka_2014.pdf.>
NCCP. Accessed May 14, 2019. https://www.nccp.health.gov.lk/pdf/publications/cancer_incidece/Cancer_Incidence_in_Sri_Lanka_2014.pdf.
|
|
3
|
Milosevic M, Jankovic D, Milenkovic A and
Stojanov D: Early diagnosis and detection of breast cancer. Technol
Health Care. 26:729–759. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Henry NL and Hayes DF: Cancer biomarkers.
Mol Oncol. 6:140–146. 2012.
|
|
5
|
National Collaborating Centre for Cancer
(UK): Familial breast cancer: Classification and care of people at
risk of familial breast cancer and management of breast cancer and
related risks in people with a family history of breast cancer,
2013.
|
|
6
|
Honrado E, Benítez J and Palacios J: The
molecular pathology of hereditary breast cancer: Genetic testing
and therapeutic implications. Mod Pathol. 18:1305–1320.
2005.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Apostolou P and Fostira F: Hereditary
breast cancer: The era of new susceptibility genes. BioMed Res Int.
2013(747318)2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Taanman JW: The mitochondrial genome:
Structure, transcription, translation and replication. Biochim
Biophys Acta. 1410:103–123. 1999.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Weerts MJA, Sleijfer S and Martens JWM:
The role of mitochondrial DNA in breast tumors. Drug Discov Today.
24:1202–1208. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tuppen HA, Blakely EL, Turnbull DM and
Taylor RW: Mitochondrial DNA mutations and human disease. Biochim
Biophys Acta. 1797:113–128. 2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Clayton DA: Mitochondrial DNA replication:
What we know. IUBMB Life. 55:213–217. 2003.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Gammage PA and Frezza C: Mitochondrial
DNA: The overlooked oncogenome? BMC Biol. 17(53)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hopkins JF, Sabelnykova VY, Weischenfeldt
J, Simon R, Aguiar JA, Alkallas R, Heisler LE, Zhang J, Watson JD,
Chua MLK, et al: Mitochondrial mutations drive prostrate cancer
aggression. Nat Commun. 8(656)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bussard KM and Siracusa LD: Understanding
mitochondrial polymorphisms in cancer. Cancer Res. 77:6051–6059.
2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wallace DC: Mitochondria and cancer:
Warburg addressed. Cold Spring Harb Symp Quant Biol. 70:363–374.
2005.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Strimbu K and Tavel JA: What are
biomarkers? Curr Opin HIV AIDS. 5:463–466. 2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Walsh MF, Nathanson KL, Couch FJ and Offit
K: Genomic biomarkers for breast cancer risk. Adv Exp Med Biol.
882:1–32. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Weigel MT and Dowsett M: Current and
emerging biomarkers in breast cancer: Prognosis and prediction.
Endocr Relat Cancer. 17:R245–R262. 2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Moyer VA; U.S. Preventive Services Task
Force: Risk assessment, genetic counselling and genetic testing for
BRCA-related cancer in women: US preventative services task force
recommendation statement. Ann Internal Med 160: 271-281, 2014.
https://annals.org/aim/fullarticle/1791499/risk-assessment-genetic-counseling-genetic-testing-brca-related-cancer-women.
|
|
20
|
Cheang MC, Chia SK, Voduc D, Gao D, Leung
S, Snider J, Watson M, Davies S, Bernard PS, Parker JS, et al: Ki67
index, HER2 status and prognosis of patients with Luminal B breast
cancer. J Natl Cancer Inst. 101:736–350. 2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Cai FF, Kohler C, Zhang B, Chen WJ,
Barekati Z, Garritsen HS, Lenner P, Toniolo P, Zhang JJ and Zhong
XY: Mutations of mitochondrial DNA as potential biomarkers in
breast cancer. Anticancer Res. 31:4267–4271. 2011.PubMed/NCBI
|
|
22
|
Jakupciak JP, Wang W, Markowitz ME, Ally
D, Coble M, Srivastava S, Maitra A, Barker PE, Sidransky D and
O'Connell CD: Mitochondrial DNA as a cancer biomarker. J Mol Diagn.
7:258–267. 2005.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Salgado J, Honorato B and García-Foncillas
J: Review: Mitochondrial defects in breast cancer. Clin Med Oncol.
2:199–207. 2008.PubMed/NCBI View
Article : Google Scholar
|
|
24
|
Wang Y, Liu VW, Tsang PC, Chiu PM, Cheung
AN, Khoo US, Nagley P and Ngan HY: Microsatelite instability in
mitochondrial genome of common female cancers. Int J Gynecol
Cancer. 1 (Suppl 16):S259–S266. 2006.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bai RK, Leal SM, Covarrubias D, Liu A and
Wong LJ: Mitochondrial genetic background modifies breast cancer
risk. Cancer Res. 67:4687–4694. 2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tipirisetti NR, Govatati S, Pullari P,
Malempati S, Thupurani MK, Perugu S, Guruvaiah P, Rao KL, Digumarti
RR, Nallanchakravarthula V, et al: Mitochondrial control region
alterations and breast cancer risk: A study in South Indian
population. PLoS One. 9(e85363)2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Ranaweera L, Kaewsutthi S, Win Tun A,
Boonyarit H, Poolsuwan S and Lertrit P: Mitochondrial DNA history
of Sri Lankan ethnic people: Their relations within the island and
with the Indian sub-continental populations. J Hum Genet. 59:28–36.
2014.
|
|
28
|
Ranasinghe R, Tennekoon KH, Karunanayake
EH, Lembring M and Allen M: A study of genetic polymorphisms in
mitochondrial DNA hypervariable regions I and II of the five major
ethnic groups and Vedda population in Sri Lanka. Leg Med (Tokyo).
17:539–546. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Rahmani B, Azimi C, Omranipour R, Raoofian
R, Zendehdel K, Saee-Rad S and Heidari M: Mutation screening in the
mitochondrial D-loop region of tumoral and non-tumoral breast
cancer in Iranian patients. Acta Med Iran. 50:447–453.
2012.PubMed/NCBI
|
|
30
|
Sultana GN, Rahman A, Shahinuzzaman AD,
Begum RA and Hossain CF: Mitochondrial DNA mutations-candidate
biomarkers for breast cancer diagnosis in Bangladesh. Chin J
Cancer. 31:449–454. 2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Miller SA, Dykes DD and Polesky HF: A
simple salting out procedure for extracting DNA from human
nucleated cells. Nucleic Acids Res. 16(1215)1988.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Rieder MJ, Taylor SL, Tobe VO and
Nickerson DA: Automating the identification of DNA variations using
quality-based fluorescence re-sequencing: Analysis of the human
mitochondrial genome. Nucleic Acids Res. 26:967–973.
1998.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Behar DM, van Oven M, Rosset S, Metspalu
M, Loogvali EL, Silva NM, Kivisild T, Torroni A and Villems R: A
Copernican reassessment of human mitochondrial DNA tree from its
root. Am J Hum Genet. 90:675–684. 2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ranasinghe R: Mitochondrial DNA analysis,
haplotype and haplogroup determination and inference of maternal
lineage in five major ethnic groups and Vedda population in Sri
Lanka (dissertation). Institute of Biochemistry, Molecular Biology
and Biotechnology, University of Colombo, 2016.
|
|
35
|
Kloss-Brandstätter A, Pacher D, Schönherr
S, Weissensteiner H, Binna R, Specht G and Kronenberg F: HaploGrep:
A fast and reliable algorithm for automatic classification of
mitochondrial DNA haplogroups. Hum Mutat. 32:25–32. 2011.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Parson W and Dur A: EMPOP-a forensic mtDNA
database. Forensic Sci Int Genet. 1:88–92. 2007.PubMed/NCBI View Article : Google Scholar
|
|
37
|
van Oven M and Kayser M: Updated
comprehensive phylogenetic tree of global human mitochondrial DNA
variation. Hum Mutat. 30:E386–E394. 2009.PubMed/NCBI View Article : Google Scholar
|
|
38
|
GraphPad QuickCalcs: McNemar test to
analyse a matched case-control study. https://www.graphpad.com/quickcalcs/McNemar1.cfm.
Accessed August 1, 2019. https://www.graphpad.com/quickcalcs/mcNemar1.
|
|
39
|
Elston CW and Ellis IO: Pathological
prognostic factors in breast cancer. I. The value of histological
grade in breast cancer: Experience from a large study with long
term follow up. Histopathology. 19:403–410. 1991.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Stoneking M: Hypervariable sites in the
mtDNA control region are mutational hotspots. Am J Hum Genet.
67:1029–1032. 2000.PubMed/NCBI View
Article : Google Scholar
|
|
41
|
Falkenberg M: Mitochondrial DNA
replication in mammalian cells: Overview of the pathway. Essays
Biochem. 62:287–296. 2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Morozov YI and Temiakov D: Human
mitochondrial transcription initiation complexes have similar
topology on the light and heavy strand promoters. J Biol Chem.
291:13432–13435. 2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Zhu W, Qin W, Bradley P, Wessel A, Puckett
CL and Sauter ER: Mitochondrial DNA mutations in breast cancer
tissue and in matched nipple aspirate fluid. Carcinogenesis.
26:145–152. 2005.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Covarrubias D, Bai RK, Wong LC and Leal
SM: Mitochondrial DNA variant interactions modify breast cancer
risk. J Hum Genet. 53:924–928. 2008.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Schon EA, DiMauro S and Hirano M: Human
mitochondrial DNA: Roles of inherited and somatic mutations. Nat
Rev Genet. 13:878–890. 2012.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Hertweck KL and Dasgupta S: The landscape
of mtDNA modifications in cancer: A tale of two cities. Front
Oncol. 7(262)2017.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Ismaeel HM, Younan HQ and Zahid RA:
Mitochondrial DNA A10398G mutation is not associated with breast
cancer risk in a sample of Iraqi women. Curr Res J Biol Sci.
5:126–129. 2013.
|
|
48
|
Yadav N and Chandra D: Mitochondrial DNA
mutations and breast tumorigenesis. Biochim Biophys Acta.
1836:336–344. 2013.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Ma L, Fu Q, Xu B, Zhou H, Gao J, Shao X,
Xiong J, Gu Q, Wen S, Li F, et al: Breast cancer-associated
mitochondrial DNA haplogroup promotes neoplastic growth via
ROS-mediated AKT activation. Int J Cancer. 142:1786–1796.
2018.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Riley V, Erzurumluoglu AM, Rodriguez S and
Bonilla C: Mitochondrial DNA haplogroups and breast cancer risk
factors in the avon longitudinal study of parents and children
(ALSPAC). Genes (Basel). 9(E395)2018.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Yu M: Circulating cell-free mitochondrial
DNA as a cancer biomarker: Opportunities and challenges.
Mitochondrial DNA. 23:329–332. 2012.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Czarnecka AM, Krawczyk T, Plak K, Klemba
A, Zdrozny M, Arnold RS, Kofler B, Golik P, Szybinska A, Lubinski
J, et al: Mitochondrial genotype and breast cancer predisposition.
Oncol Rep. 24:1521–1534. 2010.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Tan DJ, Bai RK and Wong LJ: Comprehensive
scanning of somatic mitochondrial DNA mutations in breast cancer.
Cancer Res. 62:972–976. 2002.PubMed/NCBI
|
|
54
|
Poulton J, Luan J, Macaulay V, Hennings S,
Mitchell J and Wareham NJ: Type 2 diabetes is associated with a
common mitochondrial variant: Evidence from a population-based
case-control study. Hum Mol Genet. 11:1581–1583. 2002.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Giovannucci E, Harlan DM, Archer MC,
Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG and
Yee D: Diabetes and cancer: A consensus report. Diabetes Care.
33:1674–1685. 2010.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Tommasi S, Favia P, Weigl S, Bianco A,
Pilato B, Russo L, Paradiso A and Petruzzella V: Mitochondrial DNA
variants and risk of familial breast cancer: An exploratory study.
Int J Oncol. 44:1691–1698. 2014.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Darvishi K, Sharma S, Bhat AK, Rai E and
Bamezai RN: Mitochondrial DNA G10398A polymorphism imparts maternal
Haplogroup N a risk for breast and esophageal cancer. Cancer Lett.
249:249–255. 2007.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Rojas K and Stuckey A: Breast cancer
epidemiology and risk factors. Clin Obstet Gynecol. 59:651–672.
2016.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Shen L, Wei J, Chen T, He J, Qu J, He X,
Jiang L, Qu Y, Fang H, Chen G, et al: Evaluating mitochondrial DNA
in patients with breast cancer and benign breast disease. J Cancer
Res Clin Oncol. 137:669–675. 2011.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Fang H, Shen L, Chen T, He J, Ding Z, Wei
J, Qu J, Chen G, Lu J and Bai Y: Cancer type-specific modulation of
mitochondrial haplogroups in breast, colorectal and thyroid cancer.
BMC Cancer. 10(421)2010.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Gochhait S, Bhatt A, Sharma S, Singh YP,
Gupta P and Bamezai RN: Concomitant presence of mutations in
mitochondrial genome and p53 in cancer development-a study in north
Indian sporadic breast and esophageal cancer patients. Int J
Cancer. 123:2580–2586. 2008.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Holt IJ and Reyes A: Human mitochondrial
DNA replication. Cold Spring Harb Perspect Biol.
4(a012971)2012.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Tan BG, Wellesley FC, Savery NJ and
Szczelkun MD: Length heterogeneity at conserved sequence block 2 in
human mitochondrial DNA acts as a rheostat for RNA polymerase
POLRMT activity. Nucleic Acids Res. 44:7817–7829. 2016.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Chatterjee A, Mambo E and Sidransky D:
Mitochondrial DNA mutations in human cancer. Oncogene.
25:4663–4674. 2006.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Xu C, Tran-Thanh D, Ma C, May K, Jung J,
Vecchiarelli J and Done SJ: Mitochondrial D310 mutation in the
early development of breast cancer. Br J Cancer. 106:1506–1511.
2012.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Aral C, Kaya H, Ataizi-Celikel C, Akkiprik
M, Sonmez O, Gulluoglu BM and Ozer A: A novel approach for rapid
screening of mitochondrial D310 polymorphism. BMC Cancer.
6(21)2006.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Agaronyan K, Morozov YI, Anikin M and
Temiakov D: Replication-transcription switch in human mitochondria.
Science. 347:548–551. 2015.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Jiménez-Morales S, Pérez-Amado CJ, Langley
E and Hidalgo-Miranda A: Overview of mitochondrial germline
variants and mutations in human disease: Focus on breast cancer
(Review). Int J Oncol. 53:923–936. 2018.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Alhomidi MA, Vedicherla B, Movva S, Rao
PK, Ahuja YR and Hasan Q: Mitochondrial D310 instability in Asian
Indian breast cancer patients. Tumour Biol. 34:2427–2432.
2013.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Parrella P, Seripa D, Matera MG, Rabitti
C, Rinaldi M, Mazzarelli P, Gravina C, Gallucci M, Altomare V,
Flammia G, et al: Mutations of the D310 mitochondrial
mononucleotide repeat in primary tumors and cytological specimens.
Cancer Lett. 190:73–77. 2003.PubMed/NCBI View Article : Google Scholar
|
